Forty-Eight US FDA Drug Application Decisions Delayed By Pandemic's Deferred Inspections
US FDA 'resilience' report charts how inspection backlog grew and impacted approvals and compliance follow-up.
US FDA 'resilience' report charts how inspection backlog grew and impacted approvals and compliance follow-up.